Compliance With Once-Daily Divalproex Extended-Release Tablets (Depakote-ER) Versus Multiple-Daily Dose Valproic Acid Capsules (Depakene) in Epilepsy: A Randomized, Parallel, Prospectively-Controlled Outpatient Comparison

Trial Profile

Compliance With Once-Daily Divalproex Extended-Release Tablets (Depakote-ER) Versus Multiple-Daily Dose Valproic Acid Capsules (Depakene) in Epilepsy: A Randomized, Parallel, Prospectively-Controlled Outpatient Comparison

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Oct 2015

At a glance

  • Drugs Valproate semisodium (Primary) ; Valproic acid
  • Indications Generalised seizures; Partial epilepsies
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 May 2012 Actual patient number is 5 according to ClinicalTrials.gov.
    • 31 May 2012 Actual end date (Feb 2007) added as reported by ClinicalTrials.gov.
    • 31 May 2012 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top